ATE390920T1 - Lipase inhibitoren zur behandlung von dyspepsia - Google Patents
Lipase inhibitoren zur behandlung von dyspepsiaInfo
- Publication number
- ATE390920T1 ATE390920T1 AT01980222T AT01980222T ATE390920T1 AT E390920 T1 ATE390920 T1 AT E390920T1 AT 01980222 T AT01980222 T AT 01980222T AT 01980222 T AT01980222 T AT 01980222T AT E390920 T1 ATE390920 T1 AT E390920T1
- Authority
- AT
- Austria
- Prior art keywords
- dyspepsia
- treatment
- lipase inhibitors
- lipase
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00117088 | 2000-08-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE390920T1 true ATE390920T1 (de) | 2008-04-15 |
Family
ID=8169476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01980222T ATE390920T1 (de) | 2000-08-09 | 2001-07-28 | Lipase inhibitoren zur behandlung von dyspepsia |
Country Status (17)
Country | Link |
---|---|
US (1) | US6534539B2 (de) |
EP (1) | EP1311260B1 (de) |
JP (2) | JP4727901B2 (de) |
KR (1) | KR100494245B1 (de) |
CN (1) | CN1323661C (de) |
AR (1) | AR030132A1 (de) |
AT (1) | ATE390920T1 (de) |
AU (2) | AU2002212120B2 (de) |
BR (1) | BR0113101A (de) |
CA (1) | CA2417607C (de) |
DE (1) | DE60133470T2 (de) |
DK (1) | DK1311260T3 (de) |
ES (1) | ES2304132T3 (de) |
MX (1) | MXPA03001182A (de) |
PT (1) | PT1311260E (de) |
WO (1) | WO2002011719A2 (de) |
ZA (1) | ZA200300845B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1803714A1 (de) * | 2005-12-27 | 2007-07-04 | KRKA, tovarna zdravil, d.d., Novo mesto | Verfahren zur Herstellung kristalliner Formen von Orlistat |
US8309107B2 (en) * | 2008-10-06 | 2012-11-13 | Banner Pharmacaps, Inc. | Stable solutions of orlistat for pharmaceutical dosage forms |
US20140116916A1 (en) * | 2012-10-31 | 2014-05-01 | 2294719 Ontario Limited | Therapy for Constipation |
WO2014104871A1 (en) * | 2012-12-24 | 2014-07-03 | N.V. Nutricia | Method for improving postprandial fat digestion |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1247547A (en) * | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
CA1328881C (en) | 1984-12-21 | 1994-04-26 | Pierre Barbier | Process for the manufacture of oxetanones |
CA1270837A (en) | 1984-12-21 | 1990-06-26 | Hoffmann-La Roche Limited | Oxetanones |
CA2035972C (en) | 1990-02-23 | 2006-07-11 | Martin Karpf | Process for the preparation of oxetanones |
US5274143A (en) | 1991-07-23 | 1993-12-28 | Hoffmann-La Roche Inc. | Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione |
US6004996A (en) | 1997-02-05 | 1999-12-21 | Hoffman-La Roche Inc. | Tetrahydrolipstatin containing compositions |
US6267952B1 (en) | 1998-01-09 | 2001-07-31 | Geltex Pharmaceuticals, Inc. | Lipase inhibiting polymers |
DK1105123T3 (da) | 1998-08-14 | 2004-08-09 | Hoffmann La Roche | Farmaceutiske præparater indeholdende lipase-inhibitorer og chitosan |
JP3774118B2 (ja) | 1998-08-14 | 2006-05-10 | エフ.ホフマン−ラ ロシュ アーゲー | リパーゼ阻害剤を含む製薬学的組成物 |
-
2001
- 2001-07-28 AU AU2002212120A patent/AU2002212120B2/en not_active Expired
- 2001-07-28 BR BR0113101-0A patent/BR0113101A/pt not_active IP Right Cessation
- 2001-07-28 ES ES01980222T patent/ES2304132T3/es not_active Expired - Lifetime
- 2001-07-28 AU AU1212002A patent/AU1212002A/xx active Pending
- 2001-07-28 CN CNB018139477A patent/CN1323661C/zh not_active Expired - Lifetime
- 2001-07-28 PT PT01980222T patent/PT1311260E/pt unknown
- 2001-07-28 EP EP01980222A patent/EP1311260B1/de not_active Expired - Lifetime
- 2001-07-28 KR KR10-2003-7001763A patent/KR100494245B1/ko active IP Right Grant
- 2001-07-28 AT AT01980222T patent/ATE390920T1/de active
- 2001-07-28 MX MXPA03001182A patent/MXPA03001182A/es active IP Right Grant
- 2001-07-28 WO PCT/EP2001/008776 patent/WO2002011719A2/en active IP Right Grant
- 2001-07-28 JP JP2002517055A patent/JP4727901B2/ja not_active Expired - Lifetime
- 2001-07-28 DK DK01980222T patent/DK1311260T3/da active
- 2001-07-28 CA CA002417607A patent/CA2417607C/en not_active Expired - Lifetime
- 2001-07-28 DE DE60133470T patent/DE60133470T2/de not_active Expired - Lifetime
- 2001-08-06 US US09/923,077 patent/US6534539B2/en not_active Expired - Lifetime
- 2001-08-07 AR ARP010103777A patent/AR030132A1/es unknown
-
2003
- 2003-01-30 ZA ZA200300845A patent/ZA200300845B/en unknown
-
2007
- 2007-12-25 JP JP2007331956A patent/JP4850821B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20020040049A1 (en) | 2002-04-04 |
KR20030029811A (ko) | 2003-04-16 |
EP1311260B1 (de) | 2008-04-02 |
CN1446087A (zh) | 2003-10-01 |
BR0113101A (pt) | 2003-06-24 |
AU1212002A (en) | 2002-02-18 |
AR030132A1 (es) | 2003-08-13 |
EP1311260A2 (de) | 2003-05-21 |
JP2008120821A (ja) | 2008-05-29 |
CN1323661C (zh) | 2007-07-04 |
ES2304132T3 (es) | 2008-09-16 |
JP2004505914A (ja) | 2004-02-26 |
AU2002212120B2 (en) | 2006-05-11 |
MXPA03001182A (es) | 2003-06-30 |
PT1311260E (pt) | 2008-05-02 |
JP4850821B2 (ja) | 2012-01-11 |
CA2417607A1 (en) | 2002-02-14 |
WO2002011719A2 (en) | 2002-02-14 |
DE60133470D1 (de) | 2008-05-15 |
US6534539B2 (en) | 2003-03-18 |
DK1311260T3 (da) | 2008-06-23 |
CA2417607C (en) | 2008-01-29 |
ZA200300845B (en) | 2004-04-30 |
DE60133470T2 (de) | 2009-05-07 |
WO2002011719A3 (en) | 2002-06-20 |
KR100494245B1 (ko) | 2005-06-13 |
JP4727901B2 (ja) | 2011-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60035378D1 (de) | Gerät zur Behandlung von Bandscheiben | |
DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
ATE265860T1 (de) | Impstoff zur behandlung von atherosclerosis | |
ATE275145T1 (de) | Chinazolinderivate zur behandlung von tumoren | |
DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
DE60114580D1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
DE60234760D1 (de) | Phenylindole zur behandlung von hiv | |
ATE323661T1 (de) | Behandlung von mineralischen stoffen | |
DE69934877D1 (de) | Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen | |
DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
DE60019158D1 (de) | Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien | |
DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
ATE279386T1 (de) | Retinoide zur behandlung von emphysem | |
DE60114439D1 (de) | Verfahren zur antimikrobiellen behandlung von fasermaterialien | |
DE60223688D1 (de) | Verfahren zur behandlung von multiplem myelom | |
DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
DE69835419D1 (de) | Verfahren zur Behandlung von organischem Abwasser | |
DE60035326D1 (de) | Verfahren zur Behandlung von Abwasser | |
DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
ATE273276T1 (de) | Cyclobutendion-derivate zur behandlung von artherosclerose | |
DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
DE60021252D1 (de) | Antikonvulsiva zur behandlung von autismus | |
DE60103685D1 (de) | Behandlung von Poriomania | |
ATA20122001A (de) | Verfahren zur behandlung von cellulosischen formkörpern |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1311260 Country of ref document: EP |